Pomalidomide–dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort pha...
Pomalidomide–dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial
About this item
Full title
Author / Creator
Ailawadhi, S , Mikhael, J R , LaPlant, B R , Laumann, K M , Kumar, S , Roy, V , Dingli, D , Bergsagel, P L , Buadi, F K , Rajkumar, S V , Fonseca, R , Gertz, M A , Kapoor, P , Sher, T , Hayman, S R , Stewart, A K , Dispenzieri, A , Kyle, R A , Gonsalves, W I , Reeder, C B , Lin, Y , Go, R S , Leung, N , Kourelis, T , Lust, J A , Russell, S J , Chanan-Khan, A A and Lacy, M Q
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Despite therapeutic advances, multiple myeloma remains incurable, with limited options for patients with refractory disease. We conducted a large, multi-cohort clinical trial testing various doses and treatment schedules of pomalidomide and dexamethasone (Pom/dex) in patients with refractory multiple myeloma. Overall, 345 patients were enrolled to...
Alternative Titles
Full title
Pomalidomide–dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial
Authors, Artists and Contributors
Author / Creator
Mikhael, J R
LaPlant, B R
Laumann, K M
Kumar, S
Roy, V
Dingli, D
Bergsagel, P L
Buadi, F K
Rajkumar, S V
Fonseca, R
Gertz, M A
Kapoor, P
Sher, T
Hayman, S R
Stewart, A K
Dispenzieri, A
Kyle, R A
Gonsalves, W I
Reeder, C B
Lin, Y
Go, R S
Leung, N
Kourelis, T
Lust, J A
Russell, S J
Chanan-Khan, A A
Lacy, M Q
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1936160607
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1936160607
Other Identifiers
ISSN
0887-6924
E-ISSN
1476-5551
DOI
10.1038/leu.2017.258
